Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

The clinical impact of using complex molecular profiling strategies in routine oncology practice.

Laes JF, Aftimos P, Barthelemy P, Bellmunt J, Berchem G, Camps C, Peñas RL, Finzel A, García-Foncillas J, Hervonen P, Wahid I, Joensuu T, Kathan L, Kong A, Mackay J, Mikropoulos C, Mokbel K, Mouysset JL, Odarchenko S, Perren TJ, Pienaar R, Regonesi C, Alkhayyat SS, El Kinge AR, Abulkhair O, Galal KM, Ghanem H, El Karak F, Garcia A, Ghitti G, Sadik H.

Oncotarget. 2018 Apr 17;9(29):20282-20293. doi: 10.18632/oncotarget.24757. eCollection 2018 Apr 17.

2.

Is Adjuvant Endocrine Therapy Indicated for DCIS Patients After Complete Surgical Excision?

El Hage Chehade H, Mokbel K.

Anticancer Res. 2018 Mar;38(3):1263-1266. Review.

PMID:
29491049
3.

The evolving role of pre-pectoral ADM-assisted implant-based immediate breast reconstruction following skin-sparing mastectomy.

Wazir U, Mokbel K.

Am J Surg. 2018 Feb 2. pii: S0002-9610(17)31753-1. doi: 10.1016/j.amjsurg.2018.01.021. [Epub ahead of print]

PMID:
29397895
4.

Does the Use of Hair Dyes Increase the Risk of Developing Breast Cancer? A Meta-analysis and Review of the Literature.

Gera R, Mokbel R, Igor I, Mokbel K.

Anticancer Res. 2018 Feb;38(2):707-716.

PMID:
29374694
5.

A Comparison of the Performance of EndoPredict Clinical and NHS PREDICT in 120 Patients Treated for ER-positive Breast Cancer.

Mokbel K, Wazir U, El Hage Chehade H, Manson A, Choy C, Moye V, Mokbel K.

Anticancer Res. 2017 Dec;37(12):6863-6869.

PMID:
29187466
6.

Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expression.

Linne H, Yasaei H, Marriott A, Harvey A, Mokbel K, Newbold R, Roberts T.

Oncotarget. 2017 Jun 27;8(37):61890-61900. doi: 10.18632/oncotarget.18712. eCollection 2017 Sep 22.

7.

Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?

Wazir U, Mokbel K, Carmichael A, Mokbel K.

Cell Mol Biol Lett. 2017 Sep 4;22:20. doi: 10.1186/s11658-017-0049-x. eCollection 2017. Review.

8.

Clinical Significance of PD1 and PDL1 in Human Breast Cancer.

Uhercik M, Sanders AJ, Owen S, Davies EL, Sharma AK, Jiang WG, Mokbel K.

Anticancer Res. 2017 Aug;37(8):4249-4254.

PMID:
28739716
9.

Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.

El Hage Chehade H, Wazir U, Mokbel K, Kasem A, Mokbel K.

Am J Surg. 2018 Jan;215(1):171-178. doi: 10.1016/j.amjsurg.2017.05.006. Epub 2017 Jun 3. Review.

PMID:
28622841
10.

Response to Letter: Evolving Trends in Breast Surgery: Oncoplastic to Onco-Aesthetic Surgery.

Carmichael AR, Mokbel K.

Arch Plast Surg. 2017 Jan;44(1):86. doi: 10.5999/aps.2017.44.1.86. Epub 2017 Jan 20. No abstract available.

11.

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

Wazir U, Wazir A, Wells C, Mokbel K.

Oncol Lett. 2016 Dec;12(6):4863-4868. doi: 10.3892/ol.2016.5331. Epub 2016 Nov 1.

12.

Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis.

El Hage Chehade H, Headon H, Wazir U, Abtar H, Kasem A, Mokbel K.

Am J Surg. 2017 Jan;213(1):171-180. doi: 10.1016/j.amjsurg.2016.04.019. Epub 2016 Sep 6. Review.

PMID:
27773373
13.

Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.

El Hage Chehade H, Headon H, El Tokhy O, Heeney J, Kasem A, Mokbel K.

Am J Surg. 2016 Nov;212(5):969-981. doi: 10.1016/j.amjsurg.2016.07.018. Epub 2016 Aug 16. Review.

PMID:
27671032
15.

Oncological Safety of Lipofilling in Patients with Breast Cancer: A Meta-analysis and Update on Clinical Practice.

Wazir U, El Hage Chehade H, Headon H, Oteifa M, Kasem A, Mokbel K.

Anticancer Res. 2016 Sep;36(9):4521-8. Review.

PMID:
27630291
16.

Nipple-sparing mastectomy using a hemi-periareolar incision with or without minimal medial-lateral extensions; clinical outcome and patient satisfaction: A single centre prospective observational study.

El Hage Chehade H, Headon H, Wazir U, Carmaichael AR, Choy C, Kasem A, Mokbel K.

Am J Surg. 2017 Jun;213(6):1116-1124. doi: 10.1016/j.amjsurg.2016.04.016. Epub 2016 Jul 21.

PMID:
27523925
17.

The Oncological Safety of Nipple-Sparing Mastectomy: A Systematic Review of the Literature with a Pooled Analysis of 12,358 Procedures.

Headon HL, Kasem A, Mokbel K.

Arch Plast Surg. 2016 Jul;43(4):328-38. doi: 10.5999/aps.2016.43.4.328. Epub 2016 Jul 20. Review.

18.
19.
20.
22.

Evolving Trends in Breast Surgery: Oncoplastic to Onco-Aesthetic Surgery.

Carmichael AR, Mokbel K.

Arch Plast Surg. 2016 Mar;43(2):222-3. doi: 10.5999/aps.2016.43.2.222. Epub 2016 Mar 18. No abstract available.

23.

Capsular Contracture after Breast Augmentation: An Update for Clinical Practice.

Headon H, Kasem A, Mokbel K.

Arch Plast Surg. 2015 Sep;42(5):532-43. doi: 10.5999/aps.2015.42.5.532. Epub 2015 Sep 15. Review.

24.

Breast Auto-Augmentation: A Versatile Method of Breast Rehabilitation-A Retrospective Series of 107 Procedures.

Kirwan L, Wazir U, Mokbel K.

Arch Plast Surg. 2015 Jul;42(4):438-45. doi: 10.5999/aps.2015.42.4.438. Epub 2015 Jul 14.

25.

The role of death-associated protein 3 in apoptosis, anoikis and human cancer.

Wazir U, Orakzai MM, Khanzada ZS, Jiang WG, Sharma AK, Kasem A, Mokbel K.

Cancer Cell Int. 2015 Apr 10;15:39. doi: 10.1186/s12935-015-0187-z. eCollection 2015.

26.

Breast lipofilling: a review of current practice.

Kasem A, Wazir U, Headon H, Mokbel K.

Arch Plast Surg. 2015 Mar;42(2):126-30. doi: 10.5999/aps.2015.42.2.126. Epub 2015 Mar 16. Review.

27.

Effects of the knockdown of death-associated protein 3 expression on cell adhesion, growth and migration in breast cancer cells.

Wazir U, Sanders AJ, Wazir AM, Ye L, Jiang WG, Ster IC, Sharma AK, Mokbel K.

Oncol Rep. 2015 May;33(5):2575-82. doi: 10.3892/or.2015.3825. Epub 2015 Mar 2.

PMID:
25738636
28.

The clinical implications of poly implant prothèse breast implants: an overview.

Wazir U, Kasem A, Mokbel K.

Arch Plast Surg. 2015 Jan;42(1):4-10. doi: 10.5999/aps.2015.42.1.4. Epub 2015 Jan 14. Review.

29.

Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells.

Wazir U, Sanders AJ, Wazir A, Baig RM, Jiang WG, Ster IC, Sharma AK, Mokbel K.

Oncol Rep. 2015 Mar;33(3):1450-8. doi: 10.3892/or.2014.3686. Epub 2014 Dec 22.

PMID:
25530065
30.

Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine.

Wazir U, Mokbel K.

World J Clin Oncol. 2014 Dec 10;5(5):795-9. doi: 10.5306/wjco.v5.i5.795.

31.

Towards optimal management of the axilla in the context of a positive sentinel node biopsy in early breast cancer.

Wazir U, Manson A, Mokbel K.

World J Clin Oncol. 2014 Dec 10;5(5):792-4. doi: 10.5306/wjco.v5.i5.792.

32.

In vitro and in vivo effects of suppressor of cytokine signalling 7 knockdown in breast cancer: the influence on cellular response to hepatocyte growth factor.

Sasi W, Ye L, Jiang WG, Sharma AK, Mokbel K.

Biomed Res Int. 2014;2014:648040. doi: 10.1155/2014/648040. Epub 2014 Aug 4.

33.

Towards optimal treatment of ductal carcinoma in situ.

Choy C, Mokbel K.

World J Clin Oncol. 2014 Aug 10;5(3):194-6. doi: 10.5306/wjco.v5.i3.194.

34.

Current state of mTOR targeting in human breast cancer.

Wazir U, Wazir A, Khanzada ZS, Jiang WG, Sharma AK, Mokbel K.

Cancer Genomics Proteomics. 2014 Jul-Aug;11(4):167-74. Review.

PMID:
25048346
35.

mRNA expression of DOK1-6 in human breast cancer.

Ghanem T, Bracken J, Kasem A, Jiang WG, Mokbel K.

World J Clin Oncol. 2014 May 10;5(2):156-63. doi: 10.5306/wjco.v5.i2.156.

36.

Evolving role of skin sparing mastectomy.

Kasem A, Mokbel K.

World J Clin Oncol. 2014 May 10;5(2):33-5. doi: 10.5306/wjco.v5.i2.33.

37.

The role of suppressors of cytokine signalling in human neoplasms.

Sasi W, Sharma AK, Mokbel K.

Mol Biol Int. 2014;2014:630797. doi: 10.1155/2014/630797. Epub 2014 Mar 16. Review.

38.

Bilateral florid papillomatosis of the nipple: an unusual indicator for metachronous breast cancer development-a case report.

Sasi W, Banerjee D, Mokbel K, Sharma AK.

Case Rep Oncol Med. 2014;2014:432609. doi: 10.1155/2014/432609. Epub 2014 Jan 12.

39.

The interaction between DAP1 and autophagy in the context of human carcinogenesis.

Wazir U, Khanzada ZS, Jiang WG, Sharma AK, Kasem A, Mokbel K.

Anticancer Res. 2014 Jan;34(1):1-8. Review.

PMID:
24403440
40.

The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer.

Wazir U, Ahmed MH, Bridger JM, Harvey A, Jiang WG, Sharma AK, Mokbel K.

Cell Mol Biol Lett. 2013 Dec;18(4):595-611. doi: 10.2478/s11658-013-0109-9. Epub 2013 Nov 30.

PMID:
24293108
41.

Observations on the effects of Suppressor of Cytokine Signaling 7 (SOCS7) knockdown in breast cancer cells: their in vitro response to Insulin Like Growth Factor I (IGF-I).

Sasi W, Ye L, Jiang WG, Mokbel K, Sharma A.

Clin Transl Oncol. 2014 May;16(5):476-87. doi: 10.1007/s12094-013-1107-0. Epub 2013 Sep 18.

PMID:
24046004
42.

P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer.

Wazir U, Jiang WG, Yasaei H, Linne H, Newbold RF, Mokbel K.

Anticancer Res. 2013 May;33(5):2185-9.

PMID:
23645774
43.
44.

Guanine nucleotide binding protein β 1: a novel transduction protein with a possible role in human breast cancer.

Wazir U, Jiang WG, Sharma AK, Mokbel K.

Cancer Genomics Proteomics. 2013 Mar-Apr;10(2):69-73.

PMID:
23603342
45.

Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer.

Wazir U, Newbold RF, Jiang WG, Sharma AK, Mokbel K.

Oncol Rep. 2013 May;29(5):1969-74. doi: 10.3892/or.2013.2346. Epub 2013 Mar 13.

PMID:
23503572
46.

Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.

Wazir U, Al Sarakbi W, Jiang WG, Mokbel K.

Cancer Genomics Proteomics. 2012 Nov;9(6):383-7.

PMID:
23162077
47.

Comment on prognostic and therapeutic implications of mTORC2 and rictor expression in human breast cancer.

Wazir U, Newbold RF, Jiang WG, Sharma AK, Mokbel K.

Breast Cancer Res Treat. 2012 Dec;136(3):927; author reply 928-9. doi: 10.1007/s10549-012-2248-5. Epub 2012 Sep 29. No abstract available.

PMID:
23053643
48.

The mRNA expression of DAP1 in human breast cancer: correlation with clinicopathological parameters.

Wazir U, Jiang WG, Sharma AK, Mokbel K.

Cancer Genomics Proteomics. 2012 Jul-Aug;9(4):199-201.

PMID:
22798505
49.

Ductal carcinoma in situ: recent advances and future prospects.

Lambert K, Patani N, Mokbel K.

Int J Surg Oncol. 2012;2012:347385. doi: 10.1155/2012/347385. Epub 2012 May 17.

50.

Does post-mastectomy radiotherapy represent a contraindication to skin-sparing mastectomy and immediate reconstruction: an update.

Lambert K, Mokbel K.

Surg Oncol. 2012 Jun;21(2):e67-74. doi: 10.1016/j.suronc.2011.12.007. Epub 2012 Jan 30. Review.

PMID:
22296996

Supplemental Content

Loading ...
Support Center